Saliva is a promising alternative specimen for the detection of SARS-CoV-2 in children and adults

…, E Gai, J Jumarang, L Turner, A Peralta… - Journal of clinical …, 2021 - Am Soc Microbiol
Testing efforts for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been
burdened by the scarcity of testing materials and personal protective equipment for health …

Clinical manifestations of COVID‐19 differ by age and obesity status

…, Y Lee, J Jumarang, S Perez, A Peralta… - Influenza and other …, 2022 - Wiley Online Library
Background Age and obesity status are associated with severe outcomes among hospitalized
individuals with COVID‐19. It remains unclear whether age and obesity are risk factors for …

[HTML][HTML] SARS-CoV-2 transmission dynamics in households with children, Los Angeles, California

…, S Malhotra, L Turner, A Peralta… - Frontiers in …, 2022 - frontiersin.org
Objectives: Studies of household transmission of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) focused on households with children are limited. We investigated …

Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer

…, S Campos, PA Konstantinopoulos, A Peralta… - Gynecologic …, 2019 - Elsevier
Background Improved treatment for advanced cervical cancer is needed; currently,
treatment options include combined chemotherapy and bevacizumab or pembrolizumab …

Phase 2, two-group, two-stage study of avelumab in patients (pts) with microsatellite stable (MSS), microsatellite instable (MSI), and polymerase epsilon (POLE) …

…, E Stover, AA Wright, WB Growdon, J Curtis, A Peralta… - 2019 - ascopubs.org
5502 Background: This non-randomized phase 2 study evaluated the PD-L1 inhibitor avelumab
in two cohorts of EC: i) MSI/POLE cohort including ECs with immunohistochemical (IHC) …

Phase 2, two-group, two-stage, open-label study of avelumab in patients with microsatellite stable, microsatellite instable and POLE-mutated recurrent or persistent …

…, E Stover, S Schumer, AA Wright, J Curtis, A Peralta… - 2017 - ascopubs.org
TPS5615 Background: The Cancer Genome Atlas project identified 2 groups of hypermutated
endometrial cancers (ECs): an ultramutated group that harbored mutations in the …

Urban household transmission of sars-cov-2 during periods of high and low community transmission

…, CJ Marentes Ruiz, S Malhotra, L Turner, A Peralta… - 2021 - papers.ssrn.com
Background: Household transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
significantly contributes to increased community cases. Methods: We …

Abstract CT142: A single arm, single stage phase II trial of trametinib (GSK1120212) and GSK2141795 in persistent or recurrent cervical cancer

…, A Wright, S Campos, P Konstantinopoulos, A Peralta… - Cancer Research, 2017 - AACR
Introduction: In the US, invasive cervical cancer (CC) will affect 12,710 women/year with
approximately 4,290 deaths. While screening has reduced cases in the developed world, CC …

Tumor responses and preliminary survival data in a phase II trial of ofranergene obadenovec (VB-111) combined with paclitaxel in patients with recurrent platinum …

…, SA Collins, M Birrer, S Campos, A Peralta… - 2016 - ascopubs.org
5551 Background: Ofranergene obadenovec (VB-111) is a gene therapeutic consisting of a
non-replicating adenovirus vector (Ad-5) with a modified murine pre-proendothelin promoter …

Pharmacological efficacy of aloe vera in wound healing: A narrative review

…, AN Peralta Medina… - Revista de la …, 2023 - inicib.urp.edu.pe
Aloe Vera has different therapeutic effects, including wound healing. The aim of this review
is to determine the potential efficacy of topical use of Aloe Vera in skin wound healing. A …